Novel concept to evaluate efficacy of therapeutics for ALS based on patient preference

J Neurol Neurosurg Psychiatry. 2022 May;93(5):457. doi: 10.1136/jnnp-2021-328433. Epub 2022 Jan 12.

Authors

Atsushi Hashizume^{1

2}, Masahisa Katsuno^{3

2}

Affiliations

¹ Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
² Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.
³ Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan ka2no@med.nagoya-u.ac.jp.

PMID: 35022316
DOI: 10.1136/jnnp-2021-328433

No abstract available

Keywords: ALS; scales.

Publication types

Editorial
Comment

MeSH terms

Amyotrophic Lateral Sclerosis* / drug therapy
Humans
Patient Preference